TetraLogic Pharmaceuticals' market value is the price at which a share of TetraLogic Pharmaceuticals trades on a public exchange. It measures the collective expectations of TetraLogic Pharmaceuticals Corp investors about its performance. TetraLogic Pharmaceuticals is trading at 1.0E-4 as of the 29th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of TetraLogic Pharmaceuticals Corp and determine expected loss or profit from investing in TetraLogic Pharmaceuticals over a given investment horizon. Check out TetraLogic Pharmaceuticals Correlation, TetraLogic Pharmaceuticals Volatility and TetraLogic Pharmaceuticals Alpha and Beta module to complement your research on TetraLogic Pharmaceuticals.
Please note, there is a significant difference between TetraLogic Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if TetraLogic Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TetraLogic Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
TetraLogic Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to TetraLogic Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of TetraLogic Pharmaceuticals.
0.00
01/09/2024
No Change 0.00
0.0
In 1 year 11 months and 22 days
12/29/2025
0.00
If you would invest 0.00 in TetraLogic Pharmaceuticals on January 9, 2024 and sell it all today you would earn a total of 0.00 from holding TetraLogic Pharmaceuticals Corp or generate 0.0% return on investment in TetraLogic Pharmaceuticals over 720 days. TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developin... More
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure TetraLogic Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess TetraLogic Pharmaceuticals Corp upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for TetraLogic Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as TetraLogic Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use TetraLogic Pharmaceuticals historical prices to predict the future TetraLogic Pharmaceuticals' volatility.
TetraLogic Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13 % return per unit of risk over the last 3 months. TetraLogic Pharmaceuticals Corp exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate TetraLogic Pharmaceuticals' Variance of 37.88, risk adjusted performance of (0.08), and Coefficient Of Variation of (812.40) to confirm the risk estimate we provide. The entity has a beta of 1.15, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, TetraLogic Pharmaceuticals will likely underperform. At this point, TetraLogic Pharmaceuticals has a negative expected return of -0.79%. Please make sure to validate TetraLogic Pharmaceuticals' market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to decide if TetraLogic Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
TetraLogic Pharmaceuticals Corp has no correlation between past and present. Overlapping area represents the amount of predictability between TetraLogic Pharmaceuticals time series from 9th of January 2024 to 3rd of January 2025 and 3rd of January 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of TetraLogic Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current TetraLogic Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.0
Spearman Rank Test
0.91
Residual Average
0.0
Price Variance
0.0
TetraLogic Pharmaceuticals lagged returns against current returns
Autocorrelation, which is TetraLogic Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting TetraLogic Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of TetraLogic Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that TetraLogic Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
TetraLogic Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If TetraLogic Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if TetraLogic Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in TetraLogic Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
TetraLogic Pharmaceuticals Lagged Returns
When evaluating TetraLogic Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of TetraLogic Pharmaceuticals pink sheet have on its future price. TetraLogic Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, TetraLogic Pharmaceuticals autocorrelation shows the relationship between TetraLogic Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in TetraLogic Pharmaceuticals Corp.
Other Information on Investing in TetraLogic Pink Sheet
TetraLogic Pharmaceuticals financial ratios help investors to determine whether TetraLogic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TetraLogic with respect to the benefits of owning TetraLogic Pharmaceuticals security.